Discovery - University of Dundee - Online Publications

Library & Learning Centre

Interval cancers in a FOBT-based colorectal cancer population screening programme

Standard

Interval cancers in a FOBT-based colorectal cancer population screening programme : implications for stage, gender and tumour site. / Steele, R. J. C.; McClements, P.; Watling, C.; Libby, G.; Weller, D.; Brewster, D .H.; Black, R.; Carey, F. A.; Fraser, C. G.

In: Gut, Vol. 61, No. 4, 01.04.2012, p. 576-581.

Research output: Contribution to journalArticle

Harvard

Steele, RJC, McClements, P, Watling, C, Libby, G, Weller, D, Brewster, DH, Black, R, Carey, FA & Fraser, CG 2012, 'Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site' Gut, vol 61, no. 4, pp. 576-581.

APA

Steele, R. J. C., McClements, P., Watling, C., Libby, G., Weller, D., Brewster, D. . H., Black, R., Carey, F. A., & Fraser, C. G. (2012). Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut, 61(4), 576-581doi: 10.1136/gutjnl-2011-300535

Vancouver

Steele RJC, McClements P, Watling C, Libby G, Weller D, Brewster DH et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut. 2012 Apr 1;61(4):576-581.

Author

Steele, R. J. C.; McClements, P.; Watling, C.; Libby, G.; Weller, D.; Brewster, D .H.; Black, R.; Carey, F. A.; Fraser, C. G. / Interval cancers in a FOBT-based colorectal cancer population screening programme : implications for stage, gender and tumour site.

In: Gut, Vol. 61, No. 4, 01.04.2012, p. 576-581.

Research output: Contribution to journalArticle

Bibtex - Download

@article{02d3acdc2ecd46b9ac07b1a5ec63687a,
title = "Interval cancers in a FOBT-based colorectal cancer population screening programme",
author = "Steele, {R. J. C.} and P. McClements and C. Watling and G. Libby and D. Weller and Brewster, {D .H.} and R. Black and Carey, {F. A.} and Fraser, {C. G.}",
year = "2012",
volume = "61",
number = "4",
pages = "576--581",
journal = "Gut",
issn = "0017-5749",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Interval cancers in a FOBT-based colorectal cancer population screening programme

T2 - implications for stage, gender and tumour site

A1 - Steele,R. J. C.

A1 - McClements,P.

A1 - Watling,C.

A1 - Libby,G.

A1 - Weller,D.

A1 - Brewster,D .H.

A1 - Black,R.

A1 - Carey,F. A.

A1 - Fraser,C. G.

AU - Steele,R. J. C.

AU - McClements,P.

AU - Watling,C.

AU - Libby,G.

AU - Weller,D.

AU - Brewster,D .H.

AU - Black,R.

AU - Carey,F. A.

AU - Fraser,C. G.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Background: Between 2000 and 2007, a demonstration pilot of biennial guaiac faecal occult blood test (GFOBT) screening was carried out in Scotland. Methods: Interval cancers were defined as cancers diagnosed within 2 years (ie, a complete screening round) of a negative GFOBT. The stage and outcome of the interval cancers were compared with those arising contemporaneously in the non-screened Scottish population. In addition, the gender and site distributions of the interval cancers were compared with those in the screen-detected group and the non-screened population. Results: Of the cancers diagnosed in the screened population, interval cancers comprised 31.2% in the first round, 47.7% in the second, and 58.9% in the third, although this was due to a decline in the numbers of screen-detected cancers rather than an increase in interval cancers. There were no consistent differences in the stage distribution of interval cancers and cancers from the non-screened population, and, in all three rounds, both overall and cancer-specific survival were significantly better for patients diagnosed with interval cancers (p

AB - Background: Between 2000 and 2007, a demonstration pilot of biennial guaiac faecal occult blood test (GFOBT) screening was carried out in Scotland. Methods: Interval cancers were defined as cancers diagnosed within 2 years (ie, a complete screening round) of a negative GFOBT. The stage and outcome of the interval cancers were compared with those arising contemporaneously in the non-screened Scottish population. In addition, the gender and site distributions of the interval cancers were compared with those in the screen-detected group and the non-screened population. Results: Of the cancers diagnosed in the screened population, interval cancers comprised 31.2% in the first round, 47.7% in the second, and 58.9% in the third, although this was due to a decline in the numbers of screen-detected cancers rather than an increase in interval cancers. There were no consistent differences in the stage distribution of interval cancers and cancers from the non-screened population, and, in all three rounds, both overall and cancer-specific survival were significantly better for patients diagnosed with interval cancers (p

KW - Adult

KW - Aged

KW - Article

KW - Cancer localization

KW - Cancer prognosis

KW - Cancer screening

KW - Cancer specific survival

KW - Cancer staging

KW - Clinical evaluation

KW - Colorectal cancer

KW - Controlled study

KW - Diagnostic accuracy

KW - Disease duration

KW - Female

KW - Human

KW - Major clinical study

KW - Male

KW - Occult blood test

KW - Overall survival

KW - Pathological anatomy

KW - Priority journal

KW - Sex difference

UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-84857798015&md5=51126474df03e827f6ebb04dd4945468

U2 - 10.1136/gutjnl-2011-300535

DO - 10.1136/gutjnl-2011-300535

M1 - Article

JO - Gut

JF - Gut

SN - 0017-5749

IS - 4

VL - 61

SP - 576

EP - 581

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy